As a sports fan, Dr. Clay Siegall enjoys posting articles about the different happenings in a number of leagues. He recently posted an article about how the Kansas City Chiefs sending Alex Smith to the Washington Redskins benefitted the Denver Broncos. The reason for this is that they’re in the same division and will get to twice meet the Chiefs who will be without a veteran quarterback. It’s also possible that Alex Smith will be acquired by the Broncos in the offseason in order to upgrade their quarterback position.
In other NFL news, Dr. Clay Siegall posted an article about Aaron Williams who had been a player for the Buffalo Bills. He missed all of the 2017 season due to an injury he suffered while blocking that resulted in head and neck injuries. He was their safety and he has announced that he will be retiring from the game. He had been released by the Bills and he wasn’t generating a lot of interest from other teams so he thought it was time that he retire.
Dr. Clay Siegall runs Seattle Genetics, a biotechnology firm he co-founded in 1998. He is the top executive at this company as he is both the president and chief executive officer. Through collaboration deals he has signed with other companies in the biotechnology industry he and his team develop anti-body drug conjugates into cancer fighting drugs. His first cancer drug to reach the market was Adcetris which treats two forms of lymphoma. It is distributed internationally through an agreement he signed with Takeda Pharmaceuticals.
As a cancer researcher, Dr. Clay Siegall has thirty years of experience. He started out as a researcher at the National Cancer Institute before accepting a job from Bristol-Myers Squibb six years later. He said he developed a strong interest in developing targeted cancer drugs after seeing up close that oncologists had limited tools to treat cancer when his father was diagnosed with this disease. He says even now he continues to love getting up early each day so that he and his team can make progress on providing cures for cancer.
The increases in healthcare costs are mainly due to more expensive and intense care. The main cause is the aging and growing population, although diabetes and the cost of pharmaceutical had an effect. An increase of 8.5 percent was attributed to the rise of neck and low back pain. The increase for disease care increased from $258 billion a year to $697 billion. This was despite the utilization decrease resulting in a $201 billion savings, and shorter hospital stays.
The high price of drugs has already been justified, and the savings must come from other sources, like the prevention of hospitalization. The cuts are not having enough of an effect on the cost of healthcare. Some believe the value attained with the spending is worth the cost. Future research regarding the value associated with healthcare spending is becoming essential, and people are starting to question the current costs.
Tempus is a company focused on Technology, and was co-founded by Eric Lefkofsky. Their operating system was designed to help in the battle against cancer. He is additionally one of the founders of Lightbank, a company investing in disruptive technologies. He is also well known as the Chairman and one of the founders of Groupon, the e-commerce global marketplace. Eric Lefkofsky was additionally one of the founders for Uptake Technologies, specializing in a predictive analytics platform for the biggest industries in the world, Mediaocean, a business providing integrated media procurement technology, and Echo Global Logistics, a firm concentrating on logistics and transportation outsourcing.
The Lefkofsky Family Foundation was created by Eric Lefkofsky in 2006. This charitable foundation focuses on enhancing lives within the community by using high-impact initiatives. His wife Liz also serves the foundation. Eric Lefkofsky is well known throughout the Chicago area and serves some of the most prominent charities and establishments. His education was received at the University of Michigan, and he earned his Juris Doctor at the University’s Law School. His work through Tempus has been responsible for many of the differences made by technology regarding the availability of clinical and molecular data. This has been extremely useful for the research and treatment of cancer.
Visit More : www.tempus.com/about-us/
The medical division of the University of Chicago recently became partners with a company called Tempus. Founded by Eric Lefkofsky, Tempus is a company that utilizes the latest in technology to help provide physicians with better ways to treat cancer. The partnership with UChicago will enable the educational institute’s breast cancer specialists to receive data on molecular sequencing. Combined with the comprehensive analysis Tempus has, the specialists at UChicago will be able to construct more effective treatments for breast cancer patients.
In an online article, the dean of global health for the University of Chicago spoke about the current treatments available for cancer patients. Since the amount of data for these patients is extremely limited the treatments are often based on a physician’s knowledge rather than on the specialized information provided by a patient’s genetic code. The partnership with Tempus will significantly improve the amount of information available to physicians, which in turn will improve the type of care cancer patients receive. The medical division of the University of Chicago is not the first facility to partner with Eric Lefkofsky’s company. Tempus has also partnered with such well-known institutions as the Mayo Clinic, the University of Michigan and Rush University’s medical center.
Building a Better Future
Eric Lefkofsky is no stranger to the world of business. While most people might be more familiar with his online company of Groupon, this industrious entrepreneur has helped found a number of companies including Lightbank and InnerWorkings. Mr. Lefkofsky graduated with honors from the University of Michigan, after which he went on to receive his Juris Doctor from Michigan University’s School of Law. Although he grew up in Michigan, Eric Lefkofsky migrated to the big city of Chicago, where the companies he helped to found are still headquartered today.Eric Lefkofsky’s drive to help build a better future for others can be seen in the many positions he holds outside of his own companies. He is currently a trustee for Chicago’s Lurie Children’s Hospital as well as for Chicago’s Institute of Art and its Museum of Science and Industry. He also serves as an adjunct professor for the University of Chicago.